Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:120423.
doi: 10.1155/2012/120423. Epub 2012 Jul 17.

Cerebral venous thrombosis as an extrahepatic manifestation of acute anicteric hepatitis a infection

Affiliations

Cerebral venous thrombosis as an extrahepatic manifestation of acute anicteric hepatitis a infection

Panagiotis Zis et al. Case Rep Neurol Med. 2012.

Abstract

Among the many infective causes of cerebral venous thrombosis (CVT), viral hepatitis has been regarded as a rare associated condition. We report the case of a 31-year-old woman presenting with CVT associated with hepatitis A virus (HAV) infection, outlining probable pathogenic mechanisms. We suggest that hepatitis A serological markers should be routinely included in the investigation of cerebral venous thrombosis of unknown etiology, in nonvaccinated patients with risk factors of a recent HAV exposure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cranial computerized tomography indicating left transverse sinus thrombosis. (b) Computerized tomography angiogram indicating superior sagittal and straight sinus thrombosis. (c) Magnetic resonance venography indicating the development of collateral circulation following the cerebral venous thrombosis.
Figure 2
Figure 2
(a) Alanine transaminase level over days of hospitalization, in IU/L (normal values 5–40 IU/L). (b) Total billirubin level over days of hospitalization, in mg/dL (normal values 0-1 mg/dL).

Similar articles

Cited by

References

    1. Saposnik G, Barinagarrementeria F, Brown RD, Jr., et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–1192. - PubMed
    1. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis—a review of 38 cases. Stroke. 1985;16(2):199–213. - PubMed
    1. Einhäupl KM, Villringer A, Haberl RL, et al. Clinical spectrum of sinus venous thrombosis. In: Einhäupl K, Kempski O, Baethmann A, editors. Cerebral Sinus Thrombosis. Experimental and Clinical Aspects. New York, NY, USA: Plenum Press; 1990. pp. 149–155.
    1. Einhäupl K, Bousser MG, de Bruijn SF, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. European Journal of Neurology. 2006;13(6):553–559. - PubMed
    1. Felício AC, Fukujima MM, Fiorot JA, Jr., et al. Cerebral venous thrombosis and hepatitis: case report. Arquivos de Neuro-Psiquiatria. 2006;64(4):1041–1042. - PubMed

LinkOut - more resources